Related Experiment Video
Updated: Jan 8, 2026

05:44
Author Spotlight: Double Posteromedial Approach for Treating Posterior Cruciate Ligament Cysts
Published on: October 20, 2023
1.3K
Posterior fossa arachnoid cysts in multiple system atrophy
Audrey M Blazek Ramsay1, Eoin P Flanagan1, Elizabeth A Coon1
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
IBRO Neuroscience Reports
|December 24, 2025
Summary
Three patients with posterior fossa arachnoid cysts were diagnosed with Multiple System Atrophy (MSA). This rare co-occurrence may suggest a shared mechanism or arise by chance, potentially impacting neurodegeneration.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Multiple System Atrophy (MSA) is a rare neurodegenerative disorder characterized by α-synuclein deposition in glial cells, leading to cerebellar and parkinsonian symptoms.
- The precise mechanism of α-synucleinopathy in MSA remains unclear.
- Posterior fossa arachnoid cysts are rare, benign fluid-filled sacs located in the posterior cranial fossa.
Purpose of the Study:
- To report on three patients presenting with posterior fossa arachnoid cysts who were subsequently diagnosed with clinically established Multiple System Atrophy (MSA).
- To explore the potential relationship, whether coincidental or mechanistically linked, between posterior fossa arachnoid cysts and MSA development.
Main Methods:
- Retrospective case series describing three patients with co-existing posterior fossa arachnoid cysts and MSA.
- Clinical presentation, diagnostic findings, and imaging results (including pontine and cerebellar atrophy) were analyzed.
- Statistical probability of the co-occurrence of both conditions was calculated assuming independence.
Main Results:
- Patients presented between 45-67 years with 2-3 years of progressive cerebellar symptoms and non-motor features (orthostatic hypotension, genitourinary failure, dream enactment behavior).
- All patients exhibited posterior fossa arachnoid cysts and imaging findings supportive of MSA, such as pontine and cerebellar atrophy.
- The calculated probability of the independent co-occurrence of MSA and posterior fossa arachnoid cysts is extremely low (1.09 e-6).
Conclusions:
- The co-existence of Multiple System Atrophy and posterior fossa arachnoid cysts in these three patients is statistically improbable by chance alone.
- While the concurrence is likely coincidental, the presence of space-occupying lesions like arachnoid cysts might potentially influence or accelerate neurodegenerative disease progression.
- Further research is warranted to investigate any potential shared underlying mechanisms or the impact of arachnoid cysts on neurodegeneration in MSA.
Related Concept Videos
Cranial and Spinal Meninges
3.4K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
3.4K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K

